Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

28 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Human and vector behaviors determine exposure to Anopheles in Namibia.
Mwema T, Lukubwe O, Joseph R, Maliti D, Iitula I, Katokele S, Uusiku P, Walusimbi D, Ogoma SB, Tambo M, Gueye CS, Williams YA, Vajda E, Tatarsky A, Eiseb SJ, Mumbengegwi DR, Lobo NF. Mwema T, et al. Among authors: mumbengegwi dr. Parasit Vectors. 2022 Nov 17;15(1):436. doi: 10.1186/s13071-022-05563-6. Parasit Vectors. 2022. PMID: 36397152 Free PMC article.
Study protocol for a cluster randomised controlled factorial design trial to assess the effectiveness and feasibility of reactive focal mass drug administration and vector control to reduce malaria transmission in the low endemic setting of Namibia.
Medzihradsky OF, Kleinschmidt I, Mumbengegwi D, Roberts KW, McCreesh P, Dufour MK, Uusiku P, Katokele S, Bennett A, Smith J, Sturrock H, Prach LM, Ntuku H, Tambo M, Didier B, Greenhouse B, Gani Z, Aerts A, Gosling R, Hsiang MS. Medzihradsky OF, et al. BMJ Open. 2018 Jan 27;8(1):e019294. doi: 10.1136/bmjopen-2017-019294. BMJ Open. 2018. PMID: 29374672 Free PMC article. Clinical Trial.
Subpatent malaria in a low transmission African setting: a cross-sectional study using rapid diagnostic testing (RDT) and loop-mediated isothermal amplification (LAMP) from Zambezi region, Namibia.
McCreesh P, Mumbengegwi D, Roberts K, Tambo M, Smith J, Whittemore B, Kelly G, Moe C, Murphy M, Chisenga M, Greenhouse B, Ntuku H, Kleinschmidt I, Sturrock H, Uusiku P, Gosling R, Bennett A, Hsiang MS. McCreesh P, et al. Malar J. 2018 Dec 19;17(1):480. doi: 10.1186/s12936-018-2626-5. Malar J. 2018. PMID: 30567537 Free PMC article.
Effectiveness of reactive focal mass drug administration and reactive focal vector control to reduce malaria transmission in the low malaria-endemic setting of Namibia: a cluster-randomised controlled, open-label, two-by-two factorial design trial.
Hsiang MS, Ntuku H, Roberts KW, Dufour MK, Whittemore B, Tambo M, McCreesh P, Medzihradsky OF, Prach LM, Siloka G, Siame N, Gueye CS, Schrubbe L, Wu L, Scott V, Tessema S, Greenhouse B, Erlank E, Koekemoer LL, Sturrock HJW, Mwilima A, Katokele S, Uusiku P, Bennett A, Smith JL, Kleinschmidt I, Mumbengegwi D, Gosling R. Hsiang MS, et al. Lancet. 2020 Apr 25;395(10233):1361-1373. doi: 10.1016/S0140-6736(20)30470-0. Lancet. 2020. PMID: 32334702 Free PMC article. Clinical Trial.
Community acceptance of reactive focal mass drug administration and reactive focal vector control using indoor residual spraying, a mixed-methods study in Zambezi region, Namibia.
Roberts KW, Smith Gueye C, Baltzell K, Ntuku H, McCreesh P, Maglior A, Whittemore B, Uusiku P, Mumbengegwi D, Kleinschmidt I, Gosling R, Hsiang MS. Roberts KW, et al. Malar J. 2021 Mar 22;20(1):162. doi: 10.1186/s12936-021-03679-1. Malar J. 2021. PMID: 33752673 Free PMC article.
28 results